Copyright and license

Copyright © 2024 The Author(s). This is an open access article distributed under the Creative Commons Attribution License (CC BY), which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.

How to cite

1.
Tandırcıoğlu ÜA, Alan S. The importance of transient hypothyroxinemia of prematurity and its controversial management. Turk J Pediatr 2024; 66: 147-149. https://doi.org/10.24953/turkjped.2023.744

References

  1. Maneenil G, Juthong M, Thatrimontrichai A, Janjindamai W, Dissaneevate S, Jaruratanasirikul S. Incidence and risk factors of transient hypothyroxinemia of prematurity: a prospective cohort study. Turk J Pediatr 2023; 65: 562-571. https://doi.org/10.24953/turkjped.2023.94
  2. Campos-Martorell A, Ramon AM, Barros KN, et al. Thyroid Function in 509 Premature Newborns Below 31 Weeks of Gestational Age: Evaluation and Follow-up. J Clin Res Pediatr Endocrinol 2022; 14: 453-462. https://doi.org/10.4274/jcrpe.galenos.2022.2022-2-1
  3. Yoon SA, Chang YS, Yang M, et al. Effect of levothyroxine supplementation in extremely low birth weight infants with transient hypothyroxinemia of prematurity. Sci Rep 2022; 12: 9717. https://doi.org/10.1038/s41598-022-13927-2
  4. Yilmaz A, Ozer Y, Kaya N, et al. Clinical indicators that influence a clinician’s decision to start L-thyroxine treatment in prematurity with transient hypothyroxinemia. Ital J Pediatr 2023; 49: 105. https://doi.org/10.1186/s13052-023-01516-6
  5. Iijima S. Current knowledge of transient hypothyroxinemia of prematurity: to treat or not to treat? J Matern Fetal Neonatal Med 2019; 32: 2591-2597. https://doi.org/10.1080/14767058.2018.1441277